About dmalowany

This author has not yet filled in any details.
So far dmalowany has created 3 blog entries.

Voltron Therapeutics, a Lucius Partners Company, with the VIC at MGH Announces $5.88 Million Award from U.S. DoD


Voltron Therapeutics, a Lucius Partners Company, with the VIC at MGH Announces $5.88 Million Award from U.S. DoD

Award will advance the Self-Assembling Vaccine Platform for rapid production of vaccines with Massachusetts General Hospital’s Vaccine and Immunotherapy Center

NEW YORK, NY, UNITED STATES, August 17, […]

Voltron Therapeutics, a Lucius Partners Company, with the VIC at MGH Announces $5.88 Million Award from U.S. DoD2024-01-31T15:20:07+00:00

Lucius Partners Portfolio Company Voltron Therapeutics, Inc Adds Manufacturing Expert to Scientific Advisory Board


Lucius Partners Portfolio Company Voltron Therapeutics, Inc Adds Manufacturing Expert to Scientific Advisory Board

Globally recognized manufacturing and product supply expert Tibor Nemes joins Scientific Advisory Board

NEW YORK, NY, UNITED STATES, September 14, 2023/EINPresswire.com/ — Voltron Therapeutics, Inc., […]

Lucius Partners Portfolio Company Voltron Therapeutics, Inc Adds Manufacturing Expert to Scientific Advisory Board2024-01-31T15:17:07+00:00

Lucius Partners Portfolio Company Voltron Therapeutics Announces Robust Immunogenicity Data: Key Prostate Cancer Target


Lucius Partners Portfolio Company Voltron Therapeutics Announces Robust Immunogenicity Data: Key Prostate Cancer Target

Self Assembling Vaccine targets Prostate Stem Cell Antigen Vaccine induces immunity against an immunogenic protein; expands platform’s potential targets

NEW YORK, NEW YORK, UNITED STATES, September 6, 2023/EINPresswire.com/ — Voltron Therapeutics, […]

Lucius Partners Portfolio Company Voltron Therapeutics Announces Robust Immunogenicity Data: Key Prostate Cancer Target2023-09-06T15:58:51+00:00
Go to Top